Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium
Show full item record

This item appears in the following Collection(s)

Search Deep Blue

Advanced Search

Browse by

My Account


Coming Soon

MLibrary logo